Find clinical trials for Diabetes in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus

Type 2 Diabetes Mellitus

Type 1 Diabetes Mellitus

Diabetic Foot

Obesity

Foot Ulcer

Overweight

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling

Type 1 Diabetes Mellitus

Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®

Biological: Placebo

Phase 3

Diamyd Medical

Budapest, Hungary and 59 other locations

Locations recently updated

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting

Type 2 Diabetes Mellitus

Drug: Tirzepatide

Drug: Dulaglutide

Phase 3

Lilly

Budapest, Hungary and 648 other locations

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling

Diabetes Mellitus, Type 2

Drug: AZD5004

Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca

Budapest, Hungary and 120 other locations

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

index of 27 kg/m² or more. People can take part if they have type 2 diabetes and if they are currently being treated only with diet and exer...

Active, not recruiting

Diabetes Mellitus, Type 2

Obesity

Drug: Survodutide

Drug: Placebo

Phase 3

Boehringer Ingelheim

Kistarcsa, Hungary and 146 other locations

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

help lower the blood sugar and body weight in people with type 2 diabetes. NNC0487-0111 is a new medicine which cannot be prescribed by doct...

Enrolling

Type 2 Diabetes (T2D)

Drug: Placebo (NNC0487-0111 oral)

Drug: NNC0487-0111 oral

Phase 2

Novo Nordisk

Budapest, Hungary and 102 other locations

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise (REIMAGINE 1)

This study will look at how much CagriSema helps participants with type 2 diabetes lower their blood sugar and body weight. CagriSema is a n...

Active, not recruiting

Type 2 Diabetes

Drug: Semaglutide

Drug: Placebo

Phase 3

Novo Nordisk

Budapest, Hungary and 48 other locations

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

at Week 52 in participants with overweight or obesity without diabetes mellitus (Cohort A) and in participants with overweight or obesity wi...

Active, not recruiting

Type 2 Diabetes Mellitus

Overweight

Drug: Placebo

Biological: Maridebart Cafraglutide

Phase 2

Amgen

Budapest, Hungary and 78 other locations

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5)

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Active, not recruiting

Diabetes Mellitus, Type 2

Drug: Cagrilintide

Drug: Semaglutide

Phase 3

Novo Nordisk

Budapest, Hungary and 143 other locations

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...

Active, not recruiting

Type 2 Diabetes

Chronic Kidney Disease

Drug: Cagrilintide

Drug: Semaglutide

Phase 2

Novo Nordisk

Budapest, Hungary and 121 other locations

A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration (DEUTERON)

Researchers are looking for a better way to treat participants who have diabetic macular edema (DME) or neovascular age-related macular dege...

Active, not recruiting

Diabetic Macular Edema

Neovascular Age-related Macular Degeneration

Drug: Aflibercept (BAY86-5321, Eylea)

Phase 4

Bayer

Budapest, Hungary and 7 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Diabetes in .css-epvm6{white-space:nowrap;}Budapest, Budapest

Related conditions:

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT)

Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus. (SOLSTICE)

A Study to Test Whether Survodutide (BI 456906) Helps People Living With Overweight or Obesity Who Also Have Diabetes to Lose Weight (SYNCHRONIZE™-2)

A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise (REIMAGINE 1)

Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overweight or Obesity, With or Without Type 2 Diabetes Mellitus

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both (REIMAGINE 5)

A Research Study to See if Kidney Damage in People With Chronic Kidney Disease and Type 2 Diabetes Living With Overweight or Obesity Can be Reduced by CagriSema Compared to Semaglutide, Cagrilintide and Placebo

A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration (DEUTERON)

Find clinical trials for Diabetes in Budapest, Budapest